These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15586810)

  • 41. Lipolanthionine peptides act as inhibitors of TLR2-mediated IL-8 secretion. Synthesis and structure-activity relationships.
    Seyberth T; Voss S; Brock R; Wiesmüller KH; Jung G
    J Med Chem; 2006 Mar; 49(5):1754-65. PubMed ID: 16509590
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effect of 11-deoxymisoprostol ethyl ether sodium salt on thrombocyte aggregation and prothrombin time].
    Gabdrakhmanova SF; Makara NS; Sapozhnikova TV; Baschenko NZh; Nazarov VS; Zarudiĭ FS
    Eksp Klin Farmakol; 2008; 71(2):40-2. PubMed ID: 18488906
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [New charge-deficient agmatine analogs].
    Simonian AR; Grigorenko NA; Vepsalainen J; Khomutov AR
    Bioorg Khim; 2005; 31(6):645-50. PubMed ID: 16363138
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis of novel peptide inhibitors of thrombin-induced platelet activation.
    Burke FM; Warnock M; Schmaier AH; Mosberg HI
    Chem Biol Drug Des; 2006 Nov; 68(5):235-8. PubMed ID: 17177882
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Platelet response to clopidogrel is attenuated in diabetic patients undergoing coronary stent implantation.
    Geisler T; Anders N; Paterok M; Langer H; Stellos K; Lindemann S; Herdeg C; May AE; Gawaz M
    Diabetes Care; 2007 Feb; 30(2):372-4. PubMed ID: 17259513
    [No Abstract]   [Full Text] [Related]  

  • 46. 2-Substituted 4-, 5-, and 6-[(1E)-3-oxo-3-phenylprop-1-en-1-yl]pyridazin-3(2H)-ones and 2-substituted 4,5-bis[(1E)-3-oxo-3-phenylprop-1-en-1-yl]pyridazin-3(2H)-ones as potent platelet aggregation inhibitors: design, synthesis, and SAR studies.
    Meyers C; Yáñez M; Elmaatougi A; Verhelst T; Coelho A; Fraiz N; Lemière GL; García-Mera X; Laguna R; Cano E; Maes BU; Sotelo E
    Bioorg Med Chem Lett; 2008 Jan; 18(2):793-7. PubMed ID: 18053717
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel P2Y12 adenosine diphosphate receptor antagonists for inhibition of platelet aggregation (I): in vitro effects on platelets.
    Bryant J; Post JM; Alexander S; Wang YX; Kent L; Schirm S; Tseng JL; Subramanyam B; Buckman B; Islam I; Yuan S; Sullivan ME; Snider M; Morser J
    Thromb Res; 2008; 122(4):523-32. PubMed ID: 18495218
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A new nitrate derivative of piperazine: its influence on platelet activity.
    Kostka B; Sikora J; Para J; Krajewska U; Korzycka L
    Blood Coagul Fibrinolysis; 2007 Mar; 18(2):151-6. PubMed ID: 17287632
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Synthesis of the alkyl-type glycerolipids with functional groups in their polar domain].
    Pliavnik NV; Maslov MA; Serebrennikova GA
    Bioorg Khim; 2004; 30(5):507-11. PubMed ID: 15562972
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Design, synthesis, and structure-activity relationships of a novel series of 5-alkylidenepyridazin-3(2H)-ones with a non-cAMP-based antiplatelet activity.
    Coelho A; Raviña E; Fraiz N; Yáñez M; Laguna R; Cano E; Sotelo E
    J Med Chem; 2007 Dec; 50(26):6476-84. PubMed ID: 18031002
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A palmitoylated peptide, derived from the acidic carboxyl-terminal segment of the integrin alphaIIb cytoplasmic domain, inhibits platelet activation.
    Koloka V; Christofidou ED; Vaxevanelis S; Dimitriou AA; Tsikaris V; Tselepis AD; Panou-Pomonis E; Sakarellos-Daitsiotis M; Tsoukatos DC
    Platelets; 2008 Nov; 19(7):502-11. PubMed ID: 18979362
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of acetylsalicylic acid on aggregation of human platelets by Porphyromonas gingivalis.
    Whitaker EJ; Thomas IS; Falk JA; Obebe A; Hammond BF
    Gen Dent; 2007; 55(1):64-9; quiz 70, 79-80. PubMed ID: 17333971
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Stabilization of G x C-containing DNA duplexes by polyamides with parallel orientation in the minor groove].
    Siniakov AN; Butorin AS; Héléne C; Riabinin VA
    Bioorg Khim; 2004; 30(5):558-60. PubMed ID: 15562979
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hypersensitivity of platelets to adenosine diphosphate in patients with stable cardiovascular disease predicts major adverse events despite antiplatelet therapy.
    Christie DJ; Kottke-Marchant K; Gorman RT
    Platelets; 2008 Mar; 19(2):104-10. PubMed ID: 17852773
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis, in vitro cytotoxicity and biological evaluation of twenty novel 1,3-benzenedisulfonyl piperazines as antiplatelet agents.
    Liu XJ; Wang Y; Wang X; Zhang ZH
    Bioorg Med Chem; 2021 Sep; 46():116390. PubMed ID: 34500186
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of "xanthinol niacinate" on platelet aggregation.
    Balkuv S; Akman N; Ulutin ON
    New Istanbul Contrib Clin Sci; 1967; 9(2):49-51. PubMed ID: 16300148
    [No Abstract]   [Full Text] [Related]  

  • 57. [Peptide fragments and structural analogues of chemokine MPC-1: synthesis and effect on the MPC-1-induced migration of monocytes].
    Sidorova MB; Molokoedov AS; Aref'eva TI; Kukhtina NB; Krasnikova TL; Bespalova ZhD; Bushuev VN
    Bioorg Khim; 2004; 30(6):582-93. PubMed ID: 15586809
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis of 2,3-disubstituted 1,4-naphthoquinones as antiplatelet agents.
    Lien JC; Wu CR; Hour MJ; Huang LJ; Huang TF; Kuo SC
    Arch Pharm (Weinheim); 2008 Oct; 341(10):639-44. PubMed ID: 18720342
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis, identification and antiplatelet evaluation of 2-morpholino substituted benzoxazines.
    Pritchard KM; Al-Rawi J; Bradley C
    Eur J Med Chem; 2007 Sep; 42(9):1200-10. PubMed ID: 17336427
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of preparative procedures on assay of platelet function and apparent effects of antiplatelet agents.
    Madsen NJ; Holmes CE; Serrano FA; Sobel BE; Schneider DJ
    Am J Cardiol; 2007 Aug; 100(4):722-7. PubMed ID: 17697836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.